Pcn334 - Outcomes of Peripheral T-Cell Lymphoma (Ptcl) Patients Treated in the Real World

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Factors Impacting the Real World Use of Autologous Stem Cell Transplantation (ASCT) for Newly Diagnosed Peripheral T Cell Lymphoma (PTCL)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Chidamide in the Treatment of Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy